Cargando…

The role of particle radiotherapy in the treatment of skull base tumors

The skull base is an anatomically and functionally critical area surrounded by vital structures such as the brainstem, the spinal cord, blood vessels, and cranial nerves. Due to this complexity, management of skull base tumors requires a multidisciplinary approach involving a team of specialists suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannalfi, Alberto, Riva, Giulia, Ciccone, Lucia, Orlandi, Ester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283010/
https://www.ncbi.nlm.nih.gov/pubmed/37350949
http://dx.doi.org/10.3389/fonc.2023.1161752
_version_ 1785061233546756096
author Iannalfi, Alberto
Riva, Giulia
Ciccone, Lucia
Orlandi, Ester
author_facet Iannalfi, Alberto
Riva, Giulia
Ciccone, Lucia
Orlandi, Ester
author_sort Iannalfi, Alberto
collection PubMed
description The skull base is an anatomically and functionally critical area surrounded by vital structures such as the brainstem, the spinal cord, blood vessels, and cranial nerves. Due to this complexity, management of skull base tumors requires a multidisciplinary approach involving a team of specialists such as neurosurgeons, otorhinolaryngologists, radiation oncologists, endocrinologists, and medical oncologists. In the case of pediatric patients, cancer management should be performed by a team of pediatric-trained specialists. Radiation therapy may be used alone or in combination with surgery to treat skull base tumors. There are two main types of radiation therapy: photon therapy and particle therapy. Particle radiotherapy uses charged particles (protons or carbon ions) that, due to their peculiar physical properties, permit precise targeting of the tumor with minimal healthy tissue exposure. These characteristics allow for minimizing the potential long-term effects of radiation exposure in terms of neurocognitive impairments, preserving quality of life, and reducing the risk of radio-induced cancer. For these reasons, in children, adolescents, and young adults, proton therapy should be an elective option when available. In radioresistant tumors such as chordomas and sarcomas and previously irradiated recurrent tumors, particle therapy permits the delivery of high biologically effective doses with low, or however acceptable, toxicity. Carbon ion therapy has peculiar and favorable radiobiological characteristics to overcome radioresistance features. In low-grade tumors, proton therapy should be considered in challenging cases due to tumor volume and involvement of critical neural structures. However, particle radiotherapy is still relatively new, and more research is needed to fully understand its effects. Additionally, the availability of particle therapy is limited as it requires specialized equipment and expertise. The purpose of this manuscript is to review the available literature regarding the role of particle radiotherapy in the treatment of skull base tumors.
format Online
Article
Text
id pubmed-10283010
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102830102023-06-22 The role of particle radiotherapy in the treatment of skull base tumors Iannalfi, Alberto Riva, Giulia Ciccone, Lucia Orlandi, Ester Front Oncol Oncology The skull base is an anatomically and functionally critical area surrounded by vital structures such as the brainstem, the spinal cord, blood vessels, and cranial nerves. Due to this complexity, management of skull base tumors requires a multidisciplinary approach involving a team of specialists such as neurosurgeons, otorhinolaryngologists, radiation oncologists, endocrinologists, and medical oncologists. In the case of pediatric patients, cancer management should be performed by a team of pediatric-trained specialists. Radiation therapy may be used alone or in combination with surgery to treat skull base tumors. There are two main types of radiation therapy: photon therapy and particle therapy. Particle radiotherapy uses charged particles (protons or carbon ions) that, due to their peculiar physical properties, permit precise targeting of the tumor with minimal healthy tissue exposure. These characteristics allow for minimizing the potential long-term effects of radiation exposure in terms of neurocognitive impairments, preserving quality of life, and reducing the risk of radio-induced cancer. For these reasons, in children, adolescents, and young adults, proton therapy should be an elective option when available. In radioresistant tumors such as chordomas and sarcomas and previously irradiated recurrent tumors, particle therapy permits the delivery of high biologically effective doses with low, or however acceptable, toxicity. Carbon ion therapy has peculiar and favorable radiobiological characteristics to overcome radioresistance features. In low-grade tumors, proton therapy should be considered in challenging cases due to tumor volume and involvement of critical neural structures. However, particle radiotherapy is still relatively new, and more research is needed to fully understand its effects. Additionally, the availability of particle therapy is limited as it requires specialized equipment and expertise. The purpose of this manuscript is to review the available literature regarding the role of particle radiotherapy in the treatment of skull base tumors. Frontiers Media S.A. 2023-06-07 /pmc/articles/PMC10283010/ /pubmed/37350949 http://dx.doi.org/10.3389/fonc.2023.1161752 Text en Copyright © 2023 Iannalfi, Riva, Ciccone and Orlandi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Iannalfi, Alberto
Riva, Giulia
Ciccone, Lucia
Orlandi, Ester
The role of particle radiotherapy in the treatment of skull base tumors
title The role of particle radiotherapy in the treatment of skull base tumors
title_full The role of particle radiotherapy in the treatment of skull base tumors
title_fullStr The role of particle radiotherapy in the treatment of skull base tumors
title_full_unstemmed The role of particle radiotherapy in the treatment of skull base tumors
title_short The role of particle radiotherapy in the treatment of skull base tumors
title_sort role of particle radiotherapy in the treatment of skull base tumors
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283010/
https://www.ncbi.nlm.nih.gov/pubmed/37350949
http://dx.doi.org/10.3389/fonc.2023.1161752
work_keys_str_mv AT iannalfialberto theroleofparticleradiotherapyinthetreatmentofskullbasetumors
AT rivagiulia theroleofparticleradiotherapyinthetreatmentofskullbasetumors
AT cicconelucia theroleofparticleradiotherapyinthetreatmentofskullbasetumors
AT orlandiester theroleofparticleradiotherapyinthetreatmentofskullbasetumors
AT iannalfialberto roleofparticleradiotherapyinthetreatmentofskullbasetumors
AT rivagiulia roleofparticleradiotherapyinthetreatmentofskullbasetumors
AT cicconelucia roleofparticleradiotherapyinthetreatmentofskullbasetumors
AT orlandiester roleofparticleradiotherapyinthetreatmentofskullbasetumors